NO20101215L - Fremgangsmate for fremstilling av combretastatiner - Google Patents

Fremgangsmate for fremstilling av combretastatiner

Info

Publication number
NO20101215L
NO20101215L NO20101215A NO20101215A NO20101215L NO 20101215 L NO20101215 L NO 20101215L NO 20101215 A NO20101215 A NO 20101215A NO 20101215 A NO20101215 A NO 20101215A NO 20101215 L NO20101215 L NO 20101215L
Authority
NO
Norway
Prior art keywords
preparation
combretastatin
salt
trimethoxybenzylphosphonium
nitromethoxybenzylphosphonium
Prior art date
Application number
NO20101215A
Other languages
English (en)
Other versions
NO331372B1 (no
Inventor
Michel Lavigne
Jean-Paul Casimir
Stephane Mutti
Irina Malejonock
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20101215L publication Critical patent/NO20101215L/no
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO331372B1 publication Critical patent/NO331372B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Magnetic Ceramics (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Oppfinnelsen angår nye fremgangsmåter for fremstilling av combretastatiner ved Wittig-kondensering mellom nitrometoksybenzaldehyd og et trimetoksybenzylfosfoniumsalt eller omvendt, et nitrometoksybenzylfosfoniumsalt med tnmetoksybenzaldehyd eller videre med en Wittig-reaksjon mellom de samme derivater, der nitrofunksjonen er redusert til en aminogruppe.
NO20101215A 2002-04-11 2010-09-01 Fremgangsmate for fremstilling av combretastatiner NO331372B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines
PCT/FR2003/001117 WO2003084919A2 (fr) 2002-04-11 2003-04-09 Procedes de preparation de combretastatines

Publications (2)

Publication Number Publication Date
NO20101215L true NO20101215L (no) 2004-01-07
NO331372B1 NO331372B1 (no) 2011-12-12

Family

ID=28459732

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20044814A NO329701B1 (no) 2002-04-11 2004-11-05 Fremgangsmate for fremstilling av combretastaniner og mellomprodukt for fremgangsmaten
NO20101215A NO331372B1 (no) 2002-04-11 2010-09-01 Fremgangsmate for fremstilling av combretastatiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20044814A NO329701B1 (no) 2002-04-11 2004-11-05 Fremgangsmate for fremstilling av combretastaniner og mellomprodukt for fremgangsmaten

Country Status (27)

Country Link
EP (3) EP2354118A1 (no)
JP (1) JP4299677B2 (no)
KR (1) KR101018983B1 (no)
CN (1) CN1291970C (no)
AR (2) AR039198A1 (no)
AU (1) AU2003260026B2 (no)
BR (1) BR0309087A (no)
CA (1) CA2481742C (no)
CR (1) CR7481A (no)
EA (1) EA007965B1 (no)
EC (1) ECSP045348A (no)
FR (1) FR2838437B1 (no)
HR (1) HRP20040935A2 (no)
IL (1) IL164247A0 (no)
MA (1) MA26407A1 (no)
ME (1) MEP91508A (no)
MX (1) MXPA04009112A (no)
NO (2) NO329701B1 (no)
NZ (1) NZ535318A (no)
OA (1) OA12804A (no)
PL (3) PL213967B1 (no)
RS (3) RS20110562A3 (no)
TN (1) TNSN04201A1 (no)
TW (1) TWI262179B (no)
UA (1) UA76079C2 (no)
WO (1) WO2003084919A2 (no)
ZA (1) ZA200407417B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
AU2011266635A1 (en) 2010-06-18 2013-01-10 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
UA19045A (uk) * 1988-02-24 1997-12-25 Ф.Хофманн - Ля Рош Аг Спосіб одержаhhя похідhих стильбеhу
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
CA2187214C (en) * 1994-04-06 2002-03-12 Hiroyoshi Hidaka Aminostilbazole derivative and medicine
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Also Published As

Publication number Publication date
AR082581A2 (es) 2012-12-19
IL164247A0 (en) 2005-12-18
CN1646476A (zh) 2005-07-27
PL213708B1 (pl) 2013-04-30
AR039198A1 (es) 2005-02-09
KR20040108717A (ko) 2004-12-24
UA76079C2 (en) 2006-06-15
MA26407A1 (fr) 2004-12-01
PL371629A1 (pl) 2005-06-27
PL394820A1 (pl) 2011-09-12
BR0309087A (pt) 2005-02-09
TWI262179B (en) 2006-09-21
RS20110561A3 (en) 2013-10-31
ZA200407417B (en) 2006-04-26
NO329701B1 (no) 2010-12-06
MEP91508A (bs) 2011-12-20
EP1497255A2 (fr) 2005-01-19
CN1291970C (zh) 2006-12-27
EP2354118A1 (fr) 2011-08-10
HK1075651A1 (en) 2005-12-23
CA2481742A1 (fr) 2003-10-16
JP2005522478A (ja) 2005-07-28
PL214129B1 (pl) 2013-06-28
NZ535318A (en) 2007-02-23
TW200401762A (en) 2004-02-01
HRP20040935A2 (en) 2005-10-31
AU2003260026A1 (en) 2003-10-20
EP2348012A1 (fr) 2011-07-27
JP4299677B2 (ja) 2009-07-22
KR101018983B1 (ko) 2011-03-07
OA12804A (fr) 2006-07-11
NO20044814L (no) 2004-01-07
CA2481742C (fr) 2012-06-19
FR2838437A1 (fr) 2003-10-17
RS20110561A2 (sr) 2012-10-31
FR2838437B1 (fr) 2004-06-04
CR7481A (es) 2008-11-25
PL394821A1 (pl) 2011-09-12
MXPA04009112A (es) 2004-12-07
PL213967B1 (pl) 2013-05-31
ECSP045348A (es) 2004-11-26
RS86504A (sr) 2007-02-05
WO2003084919A2 (fr) 2003-10-16
AU2003260026B2 (en) 2008-01-03
WO2003084919A3 (fr) 2004-04-08
NO331372B1 (no) 2011-12-12
TNSN04201A1 (fr) 2007-03-12
RS52331B (sr) 2012-12-31
EA200401350A1 (ru) 2005-02-24
EA007965B1 (ru) 2007-02-27
RS20110562A2 (sr) 2012-10-31
RS20110562A3 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
NO20101215L (no) Fremgangsmate for fremstilling av combretastatiner
NO971684D0 (no) Nye benzoxazoler
DK1404838T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer ved anvendelse af stammer fra enterobacteriaceae-familien, der overeksprimerer FBA
BR122012023120B8 (pt) Composto inibidor da recaptação de serotonina
NO20076660L (no) Fremgangsmate for fremstilling av rosuvastatin og mellomprodukter
CL2004000293A1 (es) Compuestos derivados de dihidrofenantridin-sulfonamidas sustituidas, sus sales; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y su uso en el tratamiento de la diabetes tipo ii, alzheimer, demencia senil, asma, col
DK1940789T3 (da) Fremgangsmåder og forbindelser til fremstilling af CC-1065-analoger
ECSP055913A (es) Inhibidores de las polimerasas víricas
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
NO20023189L (no) Fremgangsmåte for fremstilling av tolterodin og analoger derav samt intermediater fremstilt ved fremgangsmåten
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EA199900948A1 (ru) Способ получения 2-арил-3-арил-5-галогенпиридинов, используемых в качестве ингибиторов cox-2
DK1289629T3 (da) Mikrofiltrering under anvendelse af aktivt kul
ATE401382T1 (de) Zusammensetzung zur herstelllung einer wärmeisolationsbeschichtung
DK1893030T3 (da) Fremgangsmåde til fremstilling af fødevarer ved ko-ekstrudering, især pølser, og fødevarer, der opnås ved denne fremgangsmåde
CY1108121T1 (el) Διαδικασια παρασκευης ζ-φλουπεντιξολης
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
DK2046754T3 (da) Fremgangsmåde til fremstilling af alkylanilider ud fra halogenbenzenderivater
TW200745039A (en) Isotopically substituted pantoprazole
IS7021A (is) Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun
EA200870038A1 (ru) Способ получения аминов

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees